Geron GERN
NASDAQ GERN
$1.38 -0.02 (-1.78%)
As of: Sep 10, 2026 · 3:59 PM EDT

Geron (GERN) Non-Current Assets (2010 - 2026)

Geron's (GERN) quarterly Non-Current Assets came in at $32.7 million in Q2 2026, down 34.14% year-over-year from $49.6 million in Q2 2025, and down 8.2% quarter-over-quarter from $35.6 million in Q1 2026.

Analysis

Geron (GERN) Non-Current Assets (2010 - 2026) Analysis & Trends

Geron has disclosed Non-Current Assets across 17 years of filings, most recently posting $32.7 million for Q2 2026.

  • In Q2 2026, Non-Current Assets fell 34.14% year-over-year to $32.7 million; the TTM figure through Jun 2026 stood at $163.6 million (down 38.5% YoY), while the FY2025 annual figure was $50.3 million, down 51.09% from the prior year.
  • Non-Current Assets came in at $32.7 million for Q2 2026 at Geron, down from $35.6 million in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $102.8 million in Q4 2024 to a low of $10.3 million in Q4 2022.
  • Average Non-Current Assets over 5 years is $44.3 million, with a median of $41.5 million recorded in 2023.
  • Year-over-year, Non-Current Assets slumped 78.82% in 2022 and jumped 639.67% in 2023.
  • Over 5 years, Non-Current Assets stood at $10.3 million in 2022, then surged by 410.49% to $52.7 million in 2023, then surged by 94.94% to $102.8 million in 2024, then plunged by 51.09% to $50.3 million in 2025, then sank by 35.01% to $32.7 million in 2026.
  • Per Business Quant data, the three most recent Non-Current Assets figures were $32.7 million in Q2 2026, $35.6 million in Q1 2026, and $50.3 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn 60.68 Bn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn 35.42 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn 14.88 Bn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn 23.28 Bn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn 1.96 Bn
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn 5.15 Bn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn 938.60 Mn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn 24.78 Bn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn 564.41 Mn
10 Geron 914.60 Mn 613.75 Mn - 32.67 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 32.67 Mn
Mar 31, 2026 35.59 Mn
Dec 31, 2025 50.27 Mn
Sep 30, 2025 45.04 Mn
Jun 30, 2025 49.60 Mn
Mar 31, 2025 66.68 Mn
Dec 31, 2024 102.79 Mn
Sep 30, 2024 46.89 Mn
Jun 30, 2024 76.09 Mn
Mar 31, 2024 30.57 Mn
Dec 31, 2023 52.73 Mn
Sep 30, 2023 77.93 Mn
Jun 30, 2023 38.02 Mn
Mar 31, 2023 37.85 Mn
Dec 31, 2022 10.33 Mn
Sep 30, 2022 10.54 Mn
Jun 30, 2022 10.79 Mn
Mar 31, 2022 22.50 Mn
Dec 31, 2021 38.83 Mn
Sep 30, 2021 49.74 Mn